Quarterly report · Q3
4465.TEDINET S100T95G
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥17.0bn | 2023-06-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.3bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2023-06-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥756m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2023-06-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥782m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥396m | 2023-06-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥784m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥408m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥520m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥417m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥520m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥22.7bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥21.0bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.6bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥10.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.0bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.8bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.6bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥69.06 | 2023-06-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.03 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.07 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.94 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.5% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.8% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 15
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E00890-000Chemical Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥15.9bn |
| jpcrp040300-q3r_E00890-000Chemical Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥15.9bn |
| jpcrp040300-q3r_E00890-000Chemical Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥939m |
| jpcrp040300-q3r_E00890-000Healthcare Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| jpcrp040300-q3r_E00890-000Healthcare Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| jpcrp040300-q3r_E00890-000Healthcare Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥133m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥17.0bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥17.0bn |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.1bn |
| jpcrp040300-q3r_E00890-000Chemical Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥14.3bn |
| jpcrp040300-q3r_E00890-000Chemical Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥14.3bn |
| jpcrp040300-q3r_E00890-000Chemical Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥756m |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥14.3bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥14.3bn |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥756m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 353
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes | Prior1YTDDuration | 264574000 | JPY |
| Income taxes | CurrentYTDDuration | -21640000 | JPY |
| Profit loss | Prior1YTDDuration | 519922000 | JPY |
| Profit loss | CurrentYTDDuration | 417482000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 9774000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 519922000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 407707000 | JPY |
| Profit loss | Prior1YTDDuration | 519922000 | JPY |
| Profit loss | CurrentYTDDuration | 417482000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 18023000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 56686000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | -18635000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 8227000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -611000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 64913000 | JPY |
| Comprehensive income | Prior1YTDDuration | 519310000 | JPY |
| Comprehensive income | CurrentYTDDuration | 482395000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 519310000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 472620000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 9774000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00890-000ChemicalBusinessReportableSegmentsMember | 14290698000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 14290698000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 14290698000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00890-000ChemicalBusinessReportableSegmentsMember | 14290698000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 14290698000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 14290698000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00890-000ChemicalBusinessReportableSegmentsMember | 755624000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 755624000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 755624000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00890-000ChemicalBusinessReportableSegmentsMember | 15868581000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00890-000HealthcareBusinessReportableSegmentsMember | 1093350000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 16961932000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 16961932000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |